Dr Thomas Winder, Dr Andrea Sartore-Bianchi and Dr Yu Sunakawa discuss the Clinical Question: Biomarkers: when to test, what to test and what are the consequences?
Oncology
Biomarkers: when to test, what to test and what are the consequences?
Publication Date
Sep 2021
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the expertsOther programmes of interest
Video
Oncology Hemato-oncology
Early relapsed/refractory multiple myeloma (RRMM): best practices in management
A 3-part video series on managing early RRMM from leading medical experts
Experts
Dr Elena Zamagni, Dr Fredrik Schjesvold, Dr Joseph Mikhael-
Downloadable
Resources -
4 MIN
-
Sep 2024
Other
Episode
2
of 2
Oncology
Optimising samples for biomarker testing in lung, prostate and gastric cancer
Recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Aug 2024
Publication
Oncology
Advancing HCC management in Asia: insights from patients and HCPs
Paper published in Journal of Gastrointestinal Cancer
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
15 MIN
-
Jul 2024
Other
Oncology
Come and visit us in Barcelona at ESMO 2024!
Get your free professional profile photos taken with us at Booth 507
-
1 MIN
-
Jul 2024
Micro learning
Oncology Endocrinology Rare diseases
Tools for optimising treatment & management of advanced NETs
Maximising outcomes for patients with advanced neuroendocrine tumours
Experts
Prof. Emily Bergsland, Prof. Louis de MestierEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jul 2024
Video
Oncology
The evolving role of liquid biopsy in biomarker testing
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Experts
Assoc. Prof. Umberto Malapelle-
Downloadable
Resources -
5 MIN
-
Jul 2024